PREDNICORTONE 20 MG TABLETS FOR DOGS AND CATS
Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
Характеристики продукта
(SPC)
23-12-2015
Деякі документи на цей товар наразі недоступні. Ви можете надіслати запит до нашої служби підтримки, і ми повідомимо вас, як тільки ми зможемо їх отримати.
Відправляти запит.
Відправляти запит.
Активний інгредієнт:
PREDNISOLONE
Доступна з:
Le Vet Beheer B.V.
Код атс:
QH02AB06
ІПН (Міжнародна Ім'я):
PREDNISOLONE
Дозування:
20 Milligram
Фармацевтична форма:
Tablets
Тип рецепту:
POM
Терапевтична група:
Canine, Feline
Терапевтична области:
Prednisolone
Терапевтичні свідчення:
Corticosteroid
Статус Авторизація:
Authorised
Дата Авторизація:
2015-10-23
Характеристики продукта
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Prednicortone 20 mg tablets for dogs and cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 tablet contains
ACTIVE SUBSTANCE:
Prednisolone
20 mg
EXCIPIENT(S):
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet.
Light brown with brown spots, round and convex flavoured tablet with a cross-shaped break line on one side.
Tablets can be divided into 2 or 4 equal parts.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the symptomatic treatment or as adjunct treatment of inflammatory and immune-mediated diseases in dogs and
cats.
4.3 CONTRAINDICATIONS
Do not use in animals suffering from viral or mycotic infections.
Do not use in animals suffering from diabetes mellitus or hyperadrenocorticism. Do not use in animals with
osteoporosis.
Do not use in animals suffering from cardiac or renal dysfunction.
Do not use in animals suffering from corneal ulcers.
Do not use in animals with gastro-intestinal ulceration.
Do not use in animals with burns.
Do not use concomitantly with live attenuated vaccines.
Do not use in the case of glaucoma.
Do not use during pregnancy (see section 4.7).
Do not use in known cases of hypersensitivity to the active substance, to corticosteroids or to any of the excipients.
See also section 4.8.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Corticoid administration is to induce an improvement in clinical signs rather than a cure. The treatment should be
combined with treatment of the underlying disease and/or environmental control.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 08/12/2015_
_C
Прочитайте повний документ
